← Open Payments lookup

THOMAS SCHALLER: Open Payments

NPI 1578330882 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$450 in 20 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $773 · 2025 $450

Food & beverage: $450
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$118
Bausch Health US, LLC2$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Neos Therapeutics, LP2$39
Teva Pharmaceuticals USA, Inc.1$31
Lundbeck LLC1$31
Alkermes, Inc.1$28
Vanda Pharmaceuticals Inc.1$25
Tris Pharma Inc1$22
IDORSIA PHARMACEUTICALS US INC1$19

Products named: REXULTI, APLENZIN, CAPLYTA, Adzenys XR-ODT, AUSTEDO XR, ARISTADA, FANAPT, Dyanavel XR.

Industry payments across TX — which companies pay providers there.